Light Chain Amyloidosis
5 clinical trials · Condition
◉ Watch Light Chain Amyloidosis
| Record | Firm | Date |
|---|---|---|
| Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis (NCT01318902) | Millennium Pharmaceuticals, Inc. | 2011-04-27 |
Track Light Chain Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.